QA: Arrowhead Pharmaceuticals INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000879407_2025_Arrowhead_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0000879407, Arrowhead Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 695,471,000
1 IntangibleAssetsNetIncludingGoodwill 8,562,000
2 PropertyPlantAndEquipmentNet 386,032,000
3 remainder_Assets 49,737,000
4 LiabilitiesCurrent 103,168,000
5 LiabilitiesNoncurrent 845,571,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 99,402,762
9 ResearchAndDevelopmentExpense 1,266,970,348
10 remainder_Expenses -2,289,469
11 remainder_Revenues 59,122,105
12 remainder_NetIncome -11,882,395
13 remainder_ComprehensiveNetIncome -3,079,683
  yvar yval
0 Assets 1,139,802,000
1 Liabilities 948,739,000
2 Expenses 1,364,083,641
3 Revenues 59,122,105
4 StockholdersEquity 191,063,000
5 NetIncome -1,316,843,931
6 ComprehensiveNetIncome -1,318,383,772
7 BaseVar 1,763,354,412
8 EconomicCapitalRatiobeforeLimitedLiability -0.864
9 EconomicCapitalRatio 1.33

Edgar->Model Mapping

Feature Distribution

Change over Time